| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.5M | -9.9% | +5.5% |
| Cost of Revenue | $5.5M | -18.1% | +1.7% |
| Gross Profit | $16.1M | -6.7% | +6.8% |
| R&D Expense | $4.8M | -8.7% | +29.4% |
| SG&A Expense | $25.6M | -4.1% | +0.7% |
| Operating Income | -$14.4M | +2.8% | -1.9% |
| Pre-tax Income | -$13.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $76.5M | +1.4% | +20.9% |
| Accounts Receivable | $13.8M | -13.2% | +18.2% |
| Inventory | $16.2M | +0.5% | -4.2% |
| Current Assets | $111.2M | -7.3% | -21.1% |
| Total Assets | $138.3M | -6.1% | -17.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.3M | — | — |
| Capital Expenditures | $439K | — | — |
| Investing Cash Flow | $30.5M | — | — |
| Financing Cash Flow | $778K | — | — |
| Free Cash Flow | -$25.7M | — | — |
| +7.8% |
| +0.9% |
| Income Tax | $128K | -27.7% | -33.3% |
| Net Income | -$14.0M | +8.0% | +1.3% |
| EPS (Basic) | -$0.34 | +10.5% | +5.6% |
| EPS (Diluted) | -$0.34 | +10.5% | +5.6% |
| $22.9M |
| +1.9% |
| +25.0% |
| Long-term Debt | $37.1M | +0.0% | -0.3% |
| Total Liabilities | $78.2M | +0.2% | +6.5% |
| Stockholders' Equity | $60.0M | -13.1% | -36.1% |